bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.03.16.712012

A Theoretical Framework for the Hemodynamic Role of Sarcomere Length Dynamics During the Isovolumic Phases of the Left Ventricle

Abstract

The left ventricle (LV) exhibits torsional deformation during systole, and mechanical relaxation begins during the isovolumic phase. Recent advances in imaging techniques, such as MRI, have revealed that myocardial tissue deformation and sarcomere length changes occur during the isovolumic relaxation phase, even when the chamber volume remains constant. Although such ventricular deformation during the isovolumic phase is considered important for blood ejection and filling efficiency, its mechanistic contribution to contraction and relaxation remains unresolved. In this study, we hypothesized that sarcomere length dynamics during the isovolumic phase affect the isovolumic contraction and relaxation time (IVCT and IVRT) by regulating the contraction force via the force-velocity relationship of ventricular myocytes. To investigate this hypothesis, we focused on experimentally reported differences in the relationship between sarcomere length and LV volume across the endocardial and epicardial layers, as described by Rodriguez et al. We constructed and compared two types of hemodynamic models within the same integrated framework consisting of a circulation model, a LV model, and a myocardial cell contraction model by Negroni-Lascano et al., which differ only in how sarcomere length is determined: a volume-based length model (VL model), in which sarcomere length is uniquely determined by LV volume, and a volume-force-coupled length model (VFL model), in which sarcomere length is determined by the balance between LV volume and contraction force. Simulation results showed that in the VFL model, compared to the VL model, sarcomere length changed during the isovolumic phase, leading to a decrease in contractile force and shortening of IVRT, which may contribute to improved hemodynamic efficiency. These results indicate that sarcomere length dynamics can mechanically regulate force decay during isovolumic relaxation, even under constant left ventricular volume. This study provides a theoretical framework for understanding the contributions of different layers within the LV wall to diastolic function during the isovolumic relaxation phase.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

KATO, S., KISHIDA, K., HIMENO, Y., Amano, A.. 2026-03-18. A Theoretical Framework for the Hemodynamic Role of Sarcomere Length Dynamics During the Isovolumic Phases of the Left Ventricle. https://doi.org/10.64898/2026.03.16.712012

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

DEPP1 connects nutrient and oxygen availability to maintenance of muscle mass

Nutrients and oxygen are sensed within the muscle to control growth and disruption of either signal is sufficient to lead to muscle atrophy. While nutrient limitation is sensed via a conserved transcriptional atrophy program (commonly referred to as atrogenes) dictated via the Forkhead box O (FoxO) transcription factors, how low oxygen promotes muscle loss remains unknown. Accordingly, the downstream mechanisms that initiate muscle loss when oxygen and nutrients are limiting are only partly understood. Here, we find Hypoxia Inducible Factor (HIF), the master regulator of our adaptation to low oxygen, is necessary and sufficient to mediate muscle loss under hypoxia in mice. RNA sequencing in skeletal muscle isolated from starved or hypoxic mice identifies Decidual Protein Induced by Progesterone 1 (Depp1), which is induced in skeletal muscle when nutrients or oxygen is limiting via FoxO1 and HIF activation, respectively. Whole body Depp1 loss in mice reduces muscle loss under fasting and hypoxia and skeletal muscle Depp1 overexpression is sufficient to mediate muscle atrophy. Mechanistically, Depp1 localizes to the mitochondria and is necessary to control autophagy activation and mitochondrial degradation in skeletal muscle. Taken together, our studies nominate Depp1 as a new atrogene necessary for muscle loss under multiple atrophy scenarios involving FoxO and HIF.

physiology↗

The CREB-regulated co-activators 2/3, have a role, in vivo, in osteoblastic gene expression.

Many hormones and substances acting through G-protein coupled receptors and protein kinase A (PKA) activation inhibit the salt-inducible kinases (SIKs) by phosphorylation. SIKs tonically phosphorylate CREB-regulated transcriptional coactivators (CRTC1, 2 and 3), sequestering them in the cytoplasm and, thus, preventing their translocation into the nucleus. Once in the nucleus, CRTCs bind CREB family member transcription factors and enhance their activity. We and others have shown that parathyroid hormone (PTH) activation of PKA and resultant SIK2/3 inhibition allows CRTC2/3 nuclear translocation. One of the major actions of CRTC2/3 in the osteoblast lineage is the regulation of transcription of Rankl, as well as other PTH-controlled genes. However, little is known about the role of these co-activators in the osteoblast lineage in vivo. Here, we have investigated whether there are basal effects in vivo on bone examined at 2 different ages of conditional deletion of these two co-activators in the osteoblast lineage using Col2.3-Cre. We found significant increases in body weight, length, bone mineral density, bone volume/total volume, trabecular thickness and number with decreased trabecular separation in young (2 months old) male mice, all of which dissipated by 6 months of age. Female mice showed minimal changes in the bone phenotype at either age. Nevertheless, there were gene expression changes in bones of both sexes at both ages, and in particular decreases in Rankl, Runx2 and Sost, and accompanying changes in Wnt pathway genes. These effects may explain the changes in the bone phenotype in the young male mice, but it is notable that there is a sexual dimorphism in the action of CRTC2 and CRTC3. Overall, the work supports the data from research in vitro and forms a basis for investigation of the role of these co-activators in PTH action in vivo.

physiology↗

Cholinergic impairment in the dorsal motor nucleus of the vagus during experimental Alzheimer's disease

Cholinergic neurons in the dorsal motor nucleus of the vagus (DMN) in the brainstem are a key source of efferent vagus nerve fibers that regulate vital functions, including heart rate and inflammation. Whether the integrity of DMN cholinergic neurons is affected during Alzheimer's disease (AD) remains unknown. Here, in female and male mice with experimental AD (5xFAD), which exhibit age-dependent memory impairment, basal forebrain cholinergic neurodegeneration, and microglial alterations, we observe a reduction in cholinergic neuron density in the DMN at 6 and 10 months of age. Furthermore, while an important physiological function of DMN cholinergic signaling, such as suppression of heart rate, is preserved in control mice upon electrical DMN stimulation, the extent of suppression diminishes with age in both female and male 5xFAD mice. In addition, while electrical DMN stimulation lowers pro-inflammatory cytokine levels in control mice subjected to endotoxemia, this anti-inflammatory effect is diminished with age in 5xFAD mice, with females showing earlier dysfunction at 6 months. These results reveal previously unrecognized age-dependent cholinergic deficits in the DMN and disrupted brain - to - periphery vagus nerve circuits in experimental AD. These findings advance our understanding of AD mechanisms and are of interest for the development of conceptually novel therapies.

physiology↗